In one of our previous studies we found that impaired insulin action at early pregnancy predicts the later requirement of glucose lowering medications, and therefore, an increased level of insulin resistance in mothers with overweight or obesity has possible impact on treatment modalities in those patients who develop GDM (7). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.